Format

Send to

Choose Destination
Haematologica. 2019 Mar 7. pii: haematol.2018.209080. doi: 10.3324/haematol.2018.209080. [Epub ahead of print]

A clinico-molecular predictor identifies follicular lymphoma patients at risk of early transformation after first-line immunotherapy.

Author information

1
Department of Informatics, University of Oslo, Oslo, Norway.
2
Institute of Pathology, University of Würzburg, Comprehensive Cancer Centre Mainfranken.
3
Dept. of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.
4
Dept. of Medicine at Huddinge, Karolinska Institute, University Hospital, Stockholm, Sweden.
5
Dept of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.
6
Department of Oncology, Oslo University Hospital, Oslo, Norway.
7
Department of Medicine at Huddinge, Karolinska Institute, University Hospital, Stockholm, Sweden.
8
Institute of Pathology, University of Würzburg and Comprehensive Cancer Centre Mainfranken.
9
Dept. of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Norway.
10
Dept. of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway; marianne.brodtkorb@gmail.com.

KEYWORDS:

BTK; Cytogenetics and Molecular Genetics; Follicular lymphoma; Indolent Non-Hodgkin's Lymphoma; Transformation

PMID:
30846496
DOI:
10.3324/haematol.2018.209080
Free full text

Supplemental Content

Full text links

Icon for HighWire Icon for Norwegian BIBSYS system
Loading ...
Support Center